Phospholipase C-γ1 involved in brain disorders

Advances in Biological Regulation

Volumn 53, Issue 1, 2013, Pages 51-62

  Jang, Hyun Jun ^a,b   Yang, Yong Ryoul ^a   Kim, Jung Kuk ^a   Choi, Jang Hyun ^a   Seo, Young Kyo ^a   Lee, Yong Hwa ^a   Lee, Jeung Eun ^a   Ryu, Sung Ho ^b   Suh, Pann Ghill ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874001481     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2012.09.008     Document Type: Review

References (93)

1. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002, 3:383-394.
2. Amaral M.D., Pozzo-Miller L. Intracellular ca(2+) stores and ca(2+) influx are both required for BDNF to rapidly increase quantal vesicular transmitter release. Neural Plast 2012, 2012:203536.
3. Baquet Z.C., Gorski J.A., Jones K.R. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 2004, 24:4250-4258.
4. Beazely M.A., Lim A., Li H., Trepanier C., Chen X., Sidhu B., et al. Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons. J Biol Chem 2009, 284:8054-8063.
5. Becker D.J., Lowe J.B. Fucose: biosynthesis and biological function in mammals. Glycobiology 2003, 13:41R-53R.
6. Binder D.K., Routbort M.J., McNamara J.O. Immunohistochemical evidence of seizure-induced activation of trk receptors in the mossy fiber pathway of adult rat hippocampus. J Neurosci 1999, 19:4616-4626.
7. Bunney T.D., Katan M. PLC regulation: emerging pictures for molecular mechanisms. Trends Biochem Sci 2011, 36:88-96.
8. Caldeira M.V., Melo C.V., Pereira D.B., Carvalho R., Correia S.S., Backos D.S., et al. Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons. J Biol Chem 2007, 282:12619-12628.
9. Carlezon W.A., Duman R.S., Nestler E.J. The many faces of CREB. Trends Neurosci 2005, 28:436-445.
10. Chang B.S., Lowenstein D.H. Epilepsy. N Engl J Med 2003, 349:1257-1266.
11. Chen Y., Li S., Berezin V., Bock E. The fibroblast growth factor receptor (FGFR) agonist FGF1 and the neural cell adhesion molecule-derived peptide FGL activate FGFR substrate 2alpha differently. J Neurosci Res 2010, 88:1882-1889.
12. Cohen I., Navarro V., Clemenceau S., Baulac M., Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 2002, 298:1418-1421.
13. Conti F., Minelli A., Melone M. GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res Brain Res Rev 2004, 45:196-212.
14. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
15. Danzer S.C., He X., McNamara J.O. Ontogeny of seizure-induced increases in BDNF immunoreactivity and TrkB receptor activation in rat hippocampus. Hippocampus 2004, 14:345-355.
16. de Carlos J.A., Lopez-Mascaraque L., Valverde F. Dynamics of cell migration from the lateral ganglionic eminence in the rat. J Neurosci 1996, 16:6146-6156.
17. DeMattos R.B., Curtiss L.K., Williams D.L. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J Biol Chem 1998, 273:4206-4212.
18. Doherty P., Walsh F.S. CAM-FGF receptor interactions: a model for axonal growth. Mol Cell Neurosci 1996, 8:99-111.
19. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997, 54:597-606.
20. Dwivedi Y., Mondal A.C., Rizavi H.S., Shukla P.K., Pandey G.N. Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: role in LH behavior. Neuropsychopharmacol Off Pub Am Coll Neuropsychopharmacol 2005, 30:473-483.
21. Ferrer I., Goutan E., Marin C., Rey M.J., Ribalta T. Brain-derived neurotrophic factor in Huntington disease. Brain Res 2000, 866:257-261.
22. Fishell G., Mason C.A., Hatten M.E. Dispersion of neural progenitors within the germinal zones of the forebrain. Nature 1993, 362:636-638.
23. Fu G., Chen Y., Yu M., Podd A., Schuman J., He Y., et al. Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. J Exp Med 2010, 207:309-318.
24. Gartner A., Polnau D.G., Staiger V., Sciarretta C., Minichiello L., Thoenen H., et al. Hippocampal long-term potentiation is supported by presynaptic and postsynaptic tyrosine receptor kinase B-mediated phospholipase Cgamma signaling. J Neurosci 2006, 26:3496-3504.
25. Gharami K., Xie Y., An J.J., Tonegawa S., Xu B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J Neurochem 2008, 105:369-379.
26. Gilmore E.C., Herrup K. Cortical development: layers of complexity. Curr Biol 1997, 7:R231-R234.
27. Gines S., Bosch M., Marco S., Gavalda N., Diaz-Hernandez M., Lucas J.J., et al. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Eur J Neurosci 2006, 23:649-658.
28. Giralt A., Rodrigo T., Martin E.D., Gonzalez J.R., Mila M., Cena V., et al. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 2009, 158:1234-1250.
29. Goussakov I.V., Fink K., Elger C.E., Beck H. Metaplasticity of mossy fiber synaptic transmission involves altered release probability. J Neurosci 2000, 20:3434-3441.
30. Gruart A., Sciarretta C., Valenzuela-Harrington M., Delgado-Garcia J.M., Minichiello L. Mutation at the TrkB PLC{gamma}-docking site affects hippocampal LTP and associative learning in conscious mice. Learn Mem 2007, 14:54-62.
31. Gu X., Spitzer N.C. Distinct aspects of neuronal differentiation encoded by frequency of spontaneous Ca2+ transients. Nature 1995, 375:784-787.
32. Hall H., Williams E.J., Moore S.E., Walsh F.S., Prochiantz A., Doherty P. Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide. Curr Biol 1996, 6:580-587.
33. Hamanoue M., Takemoto N., Matsumoto K., Nakamura T., Nakajima K., Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 1996, 43:554-564.
34. Hardingham G.E., Bading H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci 2003, 26:81-89.
35. Hayashi H., Campenot R.B., Vance D.E., Vance J.E. Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin. J Biol Chem 2009, 284:29605-29613.
36. He X.P., Minichiello L., Klein R., McNamara J.O. Immunohistochemical evidence of seizure-induced activation of trkB receptors in the mossy fiber pathway of adult mouse hippocampus. J Neurosci 2002, 22:7502-7508.
37. He X.P., Pan E., Sciarretta C., Minichiello L., McNamara J.O. Disruption of TrkB-mediated phospholipase Cgamma signaling inhibits limbic epileptogenesis. J Neurosci 2010, 30:6188-6196.
38. Huberfeld G., Wittner L., Clemenceau S., Baulac M., Kaila K., Miles R., et al. Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 2007, 27:9866-9873.
39. Hwang S.C., Jhon D.Y., Bae Y.S., Kim J.H., Rhee S.G. Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J Biol Chem 1996, 271:18342-18349.
40. Ignatius M.J., Gebicke-Harter P.J., Skene J.H., Schilling J.W., Weisgraber K.H., Mahley R.W., et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A 1986, 83:1125-1129.
41. Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005, 1739:198-210.
42. Jefferys J.G. Advances in understanding basic mechanisms of epilepsy and seizures. Seizure: J Brit Epilepsy Assoc 2010, 19:638-646.
43. Jenkins S.M., Johnson G.V. Tau complexes with phospholipase C-gamma in situ. Neuroreport 1998, 9:67-71.
44. Ji Q.S., Winnier G.E., Niswender K.D., Horstman D., Wisdom R., Magnuson M.A., et al. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc Natl Acad Sci U S A 1997, 94:2999-3003.
45. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294:1030-1038.
46. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005, 136:29-37.
47. Katan M., Williams R.L. Phosphoinositide-specific phospholipase C: structural basis for catalysis and regulatory interactions. Semin Cell Dev Biol 1997, 8:287-296.
48. Korte M., Minichiello L., Klein R., Bonhoeffer T. Shc-binding site in the TrkB receptor is not required for hippocampal long-term potentiation. Neuropharmacol 2000, 39:717-724.
49. Law R.M., Stafford A., Quick M.W. Functional regulation of gamma-aminobutyric acid transporters by direct tyrosine phosphorylation. J Biol Chem 2000, 275:23986-23991.
50. Leidenheimer N.J. Regulation of excitation by GABA(A) receptor internalization. Results Probl Cell Differ 2008, 44:1-28.
51. Li X., Zhou J., Chen Z., Chen S., Zhu F., Zhou L. Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE). Brain Res 2008, 1221:141-146.
52. Li Y.L., Wu G.Z., Dawe G.S., Zeng L., Cui S.S., Loers G., et al. Cell surface sialylation and fucosylation are regulated by L1 via phospholipase Cgamma and cooperate to modulate neurite outgrowth, cell survival and migration. PloS One 2008, 3:e3841.
53. Liao H.J., Kume T., McKay C., Xu M.J., Ihle J.N., Carpenter G. Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. J Biol Chem 2002, 277:9335-9341.
54. Lundgren T.K., Nakahata K., Fritz N., Rebellato P., Zhang S., Uhlen P. RET PLCgamma phosphotyrosine binding domain regulates Ca2+ signaling and neocortical neuronal migration. PloS One 2012, 7:e31258.
55. Machide M., Kamitori K., Nakamura Y., Kohsaka S. Selective activation of phospholipase C gamma1 and distinct protein kinase C subspecies in intracellular signaling by hepatocyte growth factor/scatter factor in primary cultured rat neocortical cells. J Neurochem 1998, 71:592-602.
56. Machide M., Kamitori K., Kohsaka S. Hepatocyte growth factor-induced differential activation of phospholipase cgamma 1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase SHP-1 in astrocytes. J Biol Chem 2000, 275:31392-31398.
57. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
58. Matsumoto T., Numakawa T., Yokomaku D., Adachi N., Yamagishi S., Numakawa Y., et al. Brain-derived neurotrophic factor-induced potentiation of glutamate and GABA release: different dependency on signaling pathways and neuronal activity. Mol Cell Neurosci 2006, 31:70-84.
59. McNamara J.O., Huang Y.Z., Leonard A.S. Molecular signaling mechanisms underlying epileptogenesis. Science's STKE Signal Transduct Knowl Environ 2006, 2006:re12.
60. Medina D.L., Sciarretta C., Calella A.M., Von Bohlen Und Halbach O., Unsicker K., Minichiello L. TrkB regulates neocortex formation through the Shc/PLCgamma-mediated control of neuronal migration. EMBO J 2004, 23:3803-3814.
61. Milnerwood A.J., Cummings D.M., Dallerac G.M., Brown J.Y., Vatsavayai S.C., Hirst M.C., et al. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum Mol Genet 2006, 15:1690-1703.
62. Minichiello L., Calella A.M., Medina D.L., Bonhoeffer T., Klein R., Korte M. Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 2002, 36:121-137.
63. Mizoguchi Y., Kanematsu T., Hirata M., Nabekura J. A rapid increase in the total number of cell surface functional GABAA receptors induced by brain-derived neurotrophic factor in rat visual cortex. J Biol Chem 2003, 278:44097-44102.
64. Mudher A., Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands?. Trends Neurosci 2002, 25:22-26.
65. Nakata H., Nakamura S. Brain-derived neurotrophic factor regulates AMPA receptor trafficking to post-synaptic densities via IP3R and TRPC calcium signaling. FEBS Lett 2007, 581:2047-2054.
66. Natarajan D., Marcos-Gutierrez C., Pachnis V., de Graaff E. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 2002, 129:5151-5160.
67. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
68. Numakawa T., Matsumoto T., Adachi N., Yokomaku D., Kojima M., Takei N., et al. Brain-derived neurotrophic factor triggers a rapid glutamate release through increase of intracellular Ca(2+) and Na(+) in cultured cerebellar neurons. J Neurosci Res 2001, 66:96-108.
69. Numakawa T., Yamagishi S., Adachi N., Matsumoto T., Yokomaku D., Yamada M., et al. Brain-derived neurotrophic factor-induced potentiation of Ca(2+) oscillations in developing cortical neurons. J Biol Chem 2002, 277:6520-6529.
70. Paratcha G., Ledda F. GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci 2008, 31:384-391.
71. Payne J.A., Rivera C., Voipio J., Kaila K. Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci 2003, 26:199-206.
72. Rantamaki T., Hendolin P., Kankaanpaa A., Mijatovic J., Piepponen P., Domenici E., et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacol: Off Pub Am Coll Neuropsychopharmacol 2007, 32:2152-2162.
73. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988, 85:5733-5737.
74. Reynolds C.H., Garwood C.J., Wray S., Price C., Kellie S., Perera T., et al. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem 2008, 283:18177-18186.
75. Rivera C., Li H., Thomas-Crusells J., Lahtinen H., Viitanen T., Nanobashvili A., et al. BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion. J Cell Biol 2002, 159:747-752.
76. Rivera C., Voipio J., Thomas-Crusells J., Li H., Emri Z., Sipila S., et al. Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J Neurosci 2004, 24:4683-4691.
77. Sakai N., Yamada M., Numakawa T., Ogura A., Hatanaka H. BDNF potentiates spontaneous Ca2+ oscillations in cultured hippocampal neurons. Brain Res 1997, 778:318-328.
78. Shimohama S., Matsushima H., Fujimoto S., Takenawa T., Taniguchi T., Kameyama M., et al. Differential involvement of phospholipase C isozymes in Alzheimer's disease. Gerontology 1995, 41(Suppl. 1):13-19.
79. Song I., Huganir R.L. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 2002, 25:578-588.
80. Sudhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 1995, 375:645-653.
81. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 2008, 41:415-434.
82. Sutula T., Steward O. Facilitation of kindling by prior induction of long-term potentiation in the perforant path. Brain Res 1987, 420:109-117.
83. Tanaka T., Saito H., Matsuki N. Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus. J Neurosci 1997, 17:2959-2966.
84. Valenzuela C.F., Kazlauskas A., Brozowski S.J., Weiner J.L., Demali K.A., McDonald B.J., et al. Platelet-derived growth factor receptor is a novel modulator of type A gamma-aminobutyric acid-gated ion channels. Mol Pharmacol 1995, 48:1099-1107.
85. Valenzuela C.F., Xiong Z., MacDonald J.F., Weiner J.L., Frazier C.J., Dunwiddie T.V., et al. Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function. J Biol Chem 1996, 271:16151-16159.
86. Vaz S.H., Cristovao-Ferreira S., Ribeiro J.A., Sebastiao A.M. Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals. Brain Res 2008, 1219:19-25.
87. Woo N.S., Lu J., England R., McClellan R., Dufour S., Mount D.B., et al. Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. Hippocampus 2002, 12:258-268.
88. Yagasaki Y., Numakawa T., Kumamaru E., Hayashi T., Su T.P., Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem 2006, 281:12941-12949.
89. Yang F., He X., Feng L., Mizuno K., Liu X.W., Russell J., et al. PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation. Nat Neurosci 2001, 4:19-28.
90. Yang Y.R., Choi J.H., Chang J.S., Kwon H.M., Jang H.J., Ryu S.H., et al. Diverse cellular and physiological roles of phospholipase C-gamma1. Adv Enzym Regul 2011, 52:138-151.
91. Zerangue N., Kavanaugh M.P. Flux coupling in a neuronal glutamate transporter. Nature 1996, 383:634-637.
92. Zhang S.J., Steijaert M.N., Lau D., Schutz G., Delucinge-Vivier C., Descombes P., et al. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 2007, 53:549-562.
93. Zuccato C., Marullo M., Conforti P., MacDonald M.E., Tartari M., Cattaneo E. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol 2008, 18:225-238.